Changes in adsorption and permeability of mitoxantrone on plasma membrane of BCRP/MXR resistant cells
- 1 April 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 329 (1) , 64-70
- https://doi.org/10.1016/j.bbrc.2005.01.098
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- N-hexanoyl-sphingomyelin potentiates in vitro doxorubicin cytotoxicity by enhancing its cellular influxBritish Journal of Cancer, 2004
- The Role of ABC Transporters in Clinical PracticeThe Oncologist, 2003
- Relevance of drug uptake, cellular distribution and cell membrane fluidity to the enhanced sensitivity of Down's syndrome fibroblasts to anticancer antibiotic—mitoxantroneBiochimica et Biophysica Acta (BBA) - Biomembranes, 2003
- Lipids as a Target for Drugs Modulating Multidrug Resistance of Cancer CellsCurrent Drug Targets, 2003
- Sphingomyelin content conditions insertion of daunorubicin within phosphatidylcholine monolayersFEBS Letters, 2002
- Reversal of multidrug resistance and increase in plasma membrane fluidity in CHO cells with R-verapamil and bile saltsEuropean Journal Of Cancer, 2001
- Effect of ethylene oxide and propylene oxide block copolymers on the permeability of bilayer lipid membranes to small solutes including doxorubicinBiochimica et Biophysica Acta (BBA) - Biomembranes, 2000
- The relative importance of passive and P‐glycoprotein mediated anthracycline efflux from multidrug‐resistant cellsEuropean Journal of Biochemistry, 2000
- CHANGES IN PLASMA MEMBRANE FLUIDITY OF IMMORTAL RODENT CELLS INDUCED BY ANTICANCER DRUGS DOXORUBICIN, ACLARUBICIN AND MITOXANTRONECell Biology International, 1999
- Flip-Flop of Doxorubicin across Erythrocyte and Lipid MembranesBiochemical Pharmacology, 1997